- Novadaq Technologies (NASDAQ:NVDQ) perks up 9% after hours on light volume in response to the news that Cigna (CI) will cover Dermacell, a cellular dermal matrix, for use in breast reconstruction surgery and for the treatment of diabetic foot ulcers.
- Dermacell was developed by LifeNet Health and is exclusively distributed by Novadaq Technologies (NVDQ).
Cigna to cover Dermacell dermal matrix; exclusive distributor Novadaq up 9% after hours
Recommended For You
More Trending News
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
NVDQ-OLD | - | - |
Novadaq Technologies Inc. |